Bladder Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Feb 15, 2018
- Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim Mohammed et al. BMC cancer 2018 Feb 18(1) 179 - Inherited forms of bladder cancer: a review of lynch syndrome and other inherited conditions.
Phelan Aaron et al. Future oncology (London, England) 2018 Jan - Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis.
Wang Beihe et al. Scientific reports 2018 Jan 8(1) 374 - Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: a Two-Center Prospective Study.
Shindo Tetsuya et al. Urology 2017 Nov - Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.
Felsenstein Kenneth M et al. Nature reviews. Urology 2017 Nov - Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska Agnieszka et al. Proteomics. Clinical applications 2017 Oct - Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.
Boffetta Paolo et al. International journal of epidemiology 2012 Jun 41(3) 686-704 - Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
et al. JAMA oncology 2017 Feb - A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
Dahmcke Christina M et al. European urology 2016 Jul - The role of microRNAs in bladder cancer.
Enokida Hideki et al. Investigative and clinical urology 2016 Jun S60-76
No hay comentarios:
Publicar un comentario